260.000
+0,39%
2025-11-04
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +29.4% | +50.3% | 2 / 3 | -80.6% | +8.07 pp | +3.61 pp | -3.2% | 0.22 | — | 2,8 | −80,6% | 0,1 | +281,0% | — | 131.98 | — |
| Pts | 4 | 12 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 260.000 (close price on 2025-11-04)EPS (TTM): −222,7
Financial charts
1.Revenue & growth
VND bn2,75Q2/26
1.Revenue & growth
VND bn2,75Q2/26
2.Profit & growth
VND bn0,10Q2/26
3.Profit mix (Penman)
VND bn-0,40Q2/26
4.Margins & cost structure
%6.0%Q2/26
5.Returns & cash cycle
% · days-3.8%Q2/26
6.Earnings quality & cash
VND bn-7,00Q2/26
7.Asset structure
VND bn54,1Q2/26
8.Funding & debt health
VND bn · times54,1Q2/26
9.Revenue backlog
VND bn4,59Q2/26
10.Valuation
times · %-737,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %35Q2/26
Adjusted EPS growth, latest quarter
29.4%
Average adjusted EPS growth, 3 quarters
-257%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
195%
Source: vnstockData through Q2/26